Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Myomo Inc

MYO ✓ COMPLIANT ☆ Track — members

NYSE American · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Micro Cap Analyst: BUY

Last Close

$1.72

▲ +17.81%

Market Cap $68.13M · Vol 83.69K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$68.13M

Micro Cap

Div Yield

N/A

EPS Growth

+14.62%

YoY

RSI (14)

80.56

Momentum

Beta

1.60

vs Market

52W High

$1.76

2.27% below

52W Low

$0.61

182.01% above

Volume

83.69K

Avg 40.37K

P/B

3.07

Price-to-book

ROE

N/A

Return on equity

Free Float

90.32%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Myomo Inc (MYO) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MYO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+21.13%

+56.36%

+93.69%

+109.68%

YTD

+89.01%

+75.51%

+160.61%

-82.25%

Financials & Valuation

TTM · Annual

Total Revenue	$40.93M
Net Income	$-15,573,880.00
Revenue Growth (YoY)	+21.26%
Gross Margin	65.70%
Operating Margin	-35.19%
Net Profit Margin	-38.05%
ROE	N/A
ROA · ROIC	-37.26% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.93
P/B	3.07
P/FCF	N/A
EPS Growth	+14.62%
Outstanding Shares	39.61M

Technical Indicators

50-Day SMA	$1.18
200-Day SMA	$0.94
RSI (14)	80.56
Beta	1.60
52-Week High	$1.76
52-Week Low	$0.61

Volume Today	83.69K
Avg Daily Volume (30D)	40.37K
Relative Volume	2.07x
Volatility (10D)	119.55
Volatility (30D)	111.95
Free Float	90.32%

Analyst Consensus

BUY

Current Price $1.72

Mean Target $4.43

52W Low$0.61 52W High$1.76

Current

Target

$0.61 $1.76

Current Analyst target

+157.27% upside potential · 5 analysts

Identifiers

ExchangeNYSE American

FIGIBBG002B0JJW5

ISINUS62857J2015

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateNov 8, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.02% MDT Medtronic PLC +0.76% COR Cencora Inc +1.23% 7741.T Hoya Corp +0.32% BDX Becton Dickinson and Co +0.79%

Company Profile

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.